日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

视觉和计算机评估的肿瘤浸润淋巴细胞在早期三阴性乳腺癌中的预后价值(TBCRC-030)

Nader-Marta, Guilherme; Chu, Xiangying; Mukhopadhyay, Satabhisa; Abramson, Vandana G; Brufsky, Adam; Stringer-Reasor, Erica Michelle; Dent, Susan Faye; Traina, Tiffany A; Carey, Lisa A; Rimawi, Mothaffar F; Specht, Jennifer M; Miller, Kathy D; Santa-Maria, Cesar Augusto; Dasgupta, Tathagata; Kurt, Busem Binboğa; DeMeo, Michelle; Krop, Ian E; Tung, Nadine M; Schnitt, Stuart J; Tayob, Nabihah; Mayer, Erica L

Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.

源自患者的三阴性乳腺癌异种移植模型能够对化疗反应进行解卷积和预测

Lei Jonathan T, Dobrolecki Lacey E, Huang Chen, Srinivasan Ramakrishnan R, Vasaikar Suhas V, Lewis Alaina N, Sallas Christina, Zhao Na, Cao Jin, Landua John D, Moon Chang In, Liao Yuxing, Hilsenbeck Susan G, Osborne C Kent, Rimawi Mothaffar F, Ellis Matthew J, Petrosyan Varduhi, Wen Bo, Li Kai, Saltzman Alexander B, Jain Antrix, Malovannaya Anna, Wulf Gerburg M, Marangoni Elisabetta, Li Shunqiang, Kraushaar Daniel C, Wang Tao, Damodaran Senthil, Zheng Xiaofeng, Meric-Bernstam Funda, Echeverria Gloria V, Anurag Meenakshi, Chen Xi, Welm Bryan E, Welm Alana L, Zhang Bing, Lewis Michael T

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial

接受新辅助阿那曲唑、氟维司群或二者联合治疗的雌激素受体丰富/ERBB2阴性绝经后乳腺癌患者的内分泌敏感性疾病发生率:一项3期随机临床试验

Ma, Cynthia X; Suman, Vera J; Sanati, Souzan; Vij, Kiran; Anurag, Meenakshi; Leitch, A Marilyn; Unzeitig, Gary W; Hoog, Jeremy; Fernandez-Martinez, Aranzazu; Fan, Cheng; Gibbs, Richard A; Watson, Mark A; Dockter, Travis J; Hahn, Olwen; Guenther, Joseph M; Caudle, Abigail; Crouch, Erika; Tiersten, Amy; Mita, Monica; Razaq, Wajeeha; Hieken, Tina J; Wang, Yang; Rimawi, Mothaffar F; Weiss, Anna; Winer, Eric P; Hunt, Kelly K; Perou, Charles M; Ellis, Matthew J; Partridge, Ann H; Carey, Lisa A

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

来自 AURORA 美国网络的对原发性和转移性乳腺肿瘤的多组学分析发现了转移的微环境和表观遗传驱动因素

Garcia-Recio, Susana; Hinoue, Toshinori; Wheeler, Gregory L; Kelly, Benjamin J; Garrido-Castro, Ana C; Pascual, Tomas; De Cubas, Aguirre A; Xia, Youli; Felsheim, Brooke M; McClure, Marni B; Rajkovic, Andrei; Karaesmen, Ezgi; Smith, Markia A; Fan, Cheng; Ericsson, Paula I Gonzalez; Sanders, Melinda E; Creighton, Chad J; Bowen, Jay; Leraas, Kristen; Burns, Robyn T; Coppens, Sara; Wheless, Amy; Rezk, Salma; Garrett, Amy L; Parker, Joel S; Foy, Kelly K; Shen, Hui; Park, Ben H; Krop, Ian; Anders, Carey; Gastier-Foster, Julie; Rimawi, Mothaffar F; Nanda, Rita; Lin, Nancy U; Isaacs, Claudine; Marcom, P Kelly; Storniolo, Anna Maria; Couch, Fergus J; Chandran, Uma; Davis, Michael; Silverstein, Jonathan; Ropelewski, Alexander; Liu, Minetta C; Hilsenbeck, Susan G; Norton, Larry; Richardson, Andrea L; Symmans, W Fraser; Wolff, Antonio C; Davidson, Nancy E; Carey, Lisa A; Lee, Adrian V; Balko, Justin M; Hoadley, Katherine A; Laird, Peter W; Mardis, Elaine R; King, Tari A; Perou, Charles M

Pertuzumab, Trastuzumab, and an Aromatase Inhibitor for HER2-Positive and Hormone Receptor-Positive Metastatic or Locally Advanced Breast Cancer: PERTAIN Final Analysis

帕妥珠单抗、曲妥珠单抗和芳香化酶抑制剂联合治疗HER2阳性及激素受体阳性转移性或局部晚期乳腺癌:PERTAIN最终分析

Arpino, Grazia; de la Haba Rodríguez, Juan; Ferrero, Jean-Marc; De Placido, Sabino; Osborne, C Kent; Klingbiel, Dirk; Revelant, Valentine; Wohlfarth, Christine; Poppe, Raf; Rimawi, Mothaffar F

A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer

一种用于预测 HER2 阳性乳腺癌患者对新辅助拉帕替尼联合曲妥珠单抗治疗(不联合化疗)疗效的多参数分子分类器

Veeraraghavan, Jamunarani; Gutierrez, Carolina; De Angelis, Carmine; Davis, Robert; Wang, Tao; Pascual, Tomas; Selenica, Pier; Sanchez, Katherine; Nitta, Hiroaki; Kapadia, Monesh; Pavlick, Anne C; Galvan, Patricia; Rexer, Brent; Forero-Torres, Andres; Nanda, Rita; Storniolo, Anna M; Krop, Ian E; Goetz, Matthew P; Nangia, Julie R; Wolff, Antonio C; Weigelt, Britta; Reis-Filho, Jorge S; Hilsenbeck, Susan G; Prat, Aleix; Osborne, C Kent; Schiff, Rachel; Rimawi, Mothaffar F

Real-World Perspectives and Practices for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Human Epidermal Growth Factor Receptor 2-Expressing Metastatic Breast Cancer

曲妥珠单抗德鲁替康用于表达人表皮生长因子受体2的转移性乳腺癌患者发生肺炎/间质性肺病的真实世界视角和实践

Rugo, Hope S; Crossno, Christine L; Gesthalter, Yaron B; Kelley, Kristen; Moore, Heather B; Rimawi, Mothaffar F; Westbrook, Kelly E; Buys, Saundra S

Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach

利用CTD/WGCNA方法鉴定TNBC患者来源异种移植瘤中化疗反应差异的生物标志物

Petrosyan, Varduhi; Dobrolecki, Lacey E; Thistlethwaite, Lillian; Lewis, Alaina N; Sallas, Christina; Srinivasan, Ramakrishnan R; Lei, Jonathan T; Kovacevic, Vladimir; Obradovic, Predrag; Ellis, Matthew J; Osborne, C Kent; Rimawi, Mothaffar F; Pavlick, Anne; Shafaee, Maryam Nemati; Dowst, Heidi; Jain, Antrix; Saltzman, Alexander B; Malovannaya, Anna; Marangoni, Elisabetta; Welm, Alana L; Welm, Bryan E; Li, Shunqiang; Wulf, Gerburg M; Sonzogni, Olmo; Huang, Chen; Vasaikar, Suhas; Hilsenbeck, Susan G; Zhang, Bing; Milosavljevic, Aleksandar; Lewis, Michael T

Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins

基于嘌呤结合蛋白的激酶抑制剂下拉实验鉴定出三阴性乳腺癌的化疗反应特征

Wang, Junkai; Saltzman, Alexander B; Jaehnig, Eric J; Lei, Jonathan T; Malovannaya, Anna; Holt, Matthew V; Young, Meggie N; Rimawi, Mothaffar F; Ademuyiwa, Foluso O; Anurag, Meenakshi; Kim, Beom-Jun; Ellis, Matthew J